Bank of Montreal
APLS

Bank of Montreal’s Apellis Pharmaceuticals APLS Stock Holding History

Bank of Montreal’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-200
Closed -$7K – 3487
2021
Q3 		$7K Buy
+200
New +$11.2K ﹤0.01% 3729

Other funds holding APLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bank of Montreal's APLS Position: Q2 2026 in Review

Bank of Montreal sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 215,041 shares — an estimated $8.65M sold.

Bank of Montreal first reported a position in APLS in Q2 2018 and held it in 31 quarters. The position peaked at $29.6M in Q4 2023. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • Bank of Montreal reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Bank of Montreal sold 215,041 Apellis Pharmaceuticals shares in Q2 2026, an estimated $8.65M.
  • Bank of Montreal first reported a position in Apellis Pharmaceuticals in Q2 2018 and held it in 31 quarters.
  • Bank of Montreal's Apellis Pharmaceuticals position peaked at $29.6M in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.